Cuba’s five COVID-19 vaccines: the full story on Soberana 01/02/Plus, Abdala, and Mambisa - LSE Latin America and Caribbean

Despite its limited material resources, Cuba is responsible for developing two of only 23 coronavirus vaccines to have entered phase III trials anywhere in the world – and it has another three on the way. Helen Yaffe (University of Glasgow) explains how the Soberana, Abdala, and Mambisa vaccines work; how they will roll out at home and abroad; and how Cuba managed to produce them against the clock and against the odds.